4.7 Review

Development and application of Hsp90 inhibitors

Journal

DRUG DISCOVERY TODAY
Volume 13, Issue 1-2, Pages 38-43

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2007.10.007

Keywords

-

Funding

  1. NATIONAL INSTITUTE ON AGING [R21AG028811] Funding Source: NIH RePORTER
  2. NIA NIH HHS [1R21AG028811] Funding Source: Medline

Ask authors/readers for more resources

Heat shock protein 90 has emerged as an important target in several diseases. The present review will discuss our understanding of the role played by Hsp90 in regulating and maintaining the transformed phenotype in cancers and neurodegenerative diseases, as well as recent findings on its roles in fungal and viral infections. It will also update the reader on the preclinical development and clinical translation of Hsp90 inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available